22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/04/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
42 |
| 11/04/21 | 8-K | Current report filing |
|
|
32 |
| 09/30/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/26/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/26/21 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 08/19/21 | 8-K | Current report filing |
|
|
3 |
| 08/13/21 | 25 | Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange |
|
1 | |
| 08/13/21 | CERT |
|
1 | ||
| 08/12/21 | 8-A12B | Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b) |
|
1 | |
| 08/05/21 | 8-K | Current report filing |
|
|
3 |
